Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders

Details for Australian Patent Application No. 2010209273 (hide)

Owner THE MEDICAL RESEARCH, INFRASTRUCTURE, AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTER

Inventors George, Jacob; Keren, Gad

Agent Collison & Co

Pub. Number AU-A-2010209273

PCT Pub. Number WO2010/086854

Priority 61/244,530 22.09.09 US; 61/202,089 28.01.09 US

Filing date 28 January 2010

Wipo publication date 5 August 2010

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

Event Publications

1 September 2011 PCT application entered the National Phase

  PCT publication WO2010/086854 Priority application(s): WO2010/086854

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010209277-Low energy radar system

2010209265-Method for producing tooth